Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Jamieson

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|May 3, 2022
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastasesAmy Jamieson, Emily F Thompson, Jutta Huvila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial CancersAmy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2022
Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical techniqueEmily F Thompson, Lynn Hoang, Anne Kathrin Höhn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 24, 2023
Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic ApproachHang Yang, Noorah Almadani, Emily F Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence RiskEmily F Thompson, Richard W C Wong, Giorgia Trevisan, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifierAmy Jamieson, Marcel Grube, Felix Kommoss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2024
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifierAmy Jamieson, Marcel Grube, Felix Kommoss, et al.
Nature Communications|June 26, 2024
AI-based histopathology image analysis reveals a distinct subset of endometrial cancersAmirali Darbandsari, Hossein Farahani, Maryam Asadi, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|May 3, 2022
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastasesAmy Jamieson, Emily F Thompson, Jutta Huvila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial CancersAmy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2022
Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical techniqueEmily F Thompson, Lynn Hoang, Anne Kathrin Höhn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 24, 2023
Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic ApproachHang Yang, Noorah Almadani, Emily F Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence RiskEmily F Thompson, Richard W C Wong, Giorgia Trevisan, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifierAmy Jamieson, Marcel Grube, Felix Kommoss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2024
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifierAmy Jamieson, Marcel Grube, Felix Kommoss, et al.
Nature Communications|June 26, 2024
AI-based histopathology image analysis reveals a distinct subset of endometrial cancersAmirali Darbandsari, Hossein Farahani, Maryam Asadi, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Pageof 6